Also known as: SKF 2170, Androst-4-ene-3 ,17-diona, Fecundin, NSC 9563, delta-4-Androsten-3,17-dione (+13 more)
INCI: ANDROSTENEDIONE
Androstenedione (CAS 63-05-8) is a cosmetic cosmetic ingredient functioning as Hormone precursor (androgenic/estrogenic prohormone); endogenous steroid. Reported NOAEL =30 mg/kg bw/day in Rat (ToxValDB_ECHA_IUCLID); EU Regulation 1223/2009 status: prohibited. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
US NotesFDA issued warning letters to 23 companies in 2004; DEA Schedule III anabolic steroid; banned by WADA, IOC, MLB, NFL, NBA, NCAA; FDA Scientific Memorandum (2022) confirms no safe use threshold established
For full compliance data across multiple jurisdictions, use the
Substance Compliance tool.
Safety Data
Margin of Safety, dermal absorption, and sensitization profile summaries for Androstenedione.
Calculate MoS for your specific formulation with the
MoS Calculator.
Toxicological Studies
2 study endpoints found for Androstenedione. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
Endpoint
Value
Route
Species
Study Type
Source
NOAEL
=30 mg/kg bw/day
oral
Rat
reproduction developmental
ToxValDB_ECHA_IUCLID
NOAEL
=60 mg/kg bw/day
oral
Rat
developmental
ToxValDB_ECHA_IUCLID
ECHA REACH Registration
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Registration Type
Full
Tonnage Band
1 - 10 tonnes
Substance Type
SUBSTANCE
SVHC Candidate
No
PubChem Annotations
Safety and regulatory annotations from PubChem (NCBI) aggregated sources.
Safety (2)
Carcinogen Classification
Androstenedione | TR-560: Toxicology and Carcinogenesis Studies of Androstenedione (CASRN 63-05-8) in F344/N Rats and B6C3F1 Mice (Gavage Studies) (2010 ) | 02/25/09 | Equivocal Evidence | Equivocal Evidence | Clear Evidence | Clear Evidence | Under the conditions of these 2-year gavage studies, there was equivocal evidence of carcinogenic activity of androstenedione in male F344/N rats b
Source: NTP Technical Reports
Endocrine Disruptors
Potential endocrine disrupting compound
Source: NORMAN Suspect List Exchange
Function Categories & List Membership
Cosmetic/Chemical Function Categories
Pharmaceutical
Regulatory List Membership (1)
California Proposition 65 (OEHHA)
Expert Verdict
Expert safety assessment and concern-level summary for Androstenedione.
Androstenedione has a safety rating of "POOR" in our database. EU status: prohibited. US status: prohibited. 2 toxicological study endpoint(s) are available in our database.
Is Androstenedione allowed in the EU?
Androstenedione EU regulatory status: prohibited. This is based on EU Regulation 1223/2009 and its amendments.
What does Androstenedione do in cosmetics?
Androstenedione functions as: Hormone precursor (androgenic/estrogenic prohormone); endogenous steroid intermediate in biosynthesis of testosterone and estrone from DHEA. It is classified as a cosmetic ingredient in our database. CAS number: 63-05-8.
What is the NOAEL for Androstenedione?
The NOAEL (No Observed Adverse Effect Level) for Androstenedione is =30 mg/kg bw/day based on a reproduction developmental study via oral route in Rat. A total of 2 study endpoints are available. Source: ToxValDB_ECHA_IUCLID.
Is Androstenedione used outside cosmetics?
Androstenedione also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Does Androstenedione have different safety status in cosmetics vs industrial chemicals?
Androstenedione is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H351, H360, H362).
Compliance Tools
Check Androstenedione compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.